Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Number of employees : 75 000 people.
Sales per Business
20202021Delta
Medical8 680.0050.7%9 479.0046.8% +9.21%
Life Sciences4 675.0027.3%6 530.0032.3% +39.68%
Interventional3 762.0022%4 239.0020.9% +12.68%
USD in Million
Sales per region
2021
United States10 969.0054.2%
EMEA4 751.0023.5%
Greater Asia3 272.0016.2%
Other1 255.006.2%
USD in Million
Managers
Name Title Age Since
Thomas Polen Chairman, President & Chief Executive Officer 48 2021
Chris DelOrefice Chief Financial Officer & Executive Vice President - 2021
William Sigmund Chief Medical Officer & Executive Vice President - 2018
Jerry Flasz Chief Information Officer & EVP-Global Services - -
Elizabeth McCombs Chief Technology Officer & Executive VP 45 2021
Joseph Smith Chief Scientific Officer & Senior Vice President - 2021
Michelle Quinn Chief Ethics & Compliance Officer, Senior VP - 2019
Bertram L. Scott Independent Director 70 2002
Claire M. Fraser-Liggett, Dr. Independent Director 66 2006
Marshall O. Larsen Independent Director 73 2012
Members of the board
Name Title Age Since
Thomas Polen Chairman, President & Chief Executive Officer 48 2021
Bertram L. Scott Independent Director 70 2002
Claire M. Fraser-Liggett, Dr. Independent Director 66 2006
Marshall O. Larsen Independent Director 73 2012
Christopher Ian Montague Jones Independent Director 66 2010
Rebecca W. Rimel Independent Director 70 2012
Catherine M. Burzik Independent Director 71 2013
Claire Pomeroy, Dr. Independent Director 66 2014
Robert Eckert Independent Director 60 2016
Tim Ring Independent Director 64 2017
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 365,207,319 282,841,234 77.4% 80,163,949 22.0% 77.4%
Shareholders
NameEquities%
The Vanguard Group, Inc. 22,961,424 8.06%
T. Rowe Price Associates, Inc. (Investment Management) 15,440,261 5.42%
Wellington Management Co. LLP 14,489,749 5.08%
SSgA Funds Management, Inc. 12,224,521 4.29%
Morgan Stanley Investment Management Ltd. 8,178,992 2.87%
BlackRock Fund Advisors 6,042,962 2.12%
Parnassus Investments 4,706,249 1.65%
Massachusetts Financial Services Co. 4,442,013 1.56%
Geode Capital Management LLC 4,349,282 1.53%
Fundsmith LLP 4,328,550 1.52%
Company contact information
Becton, Dickinson & Co.
1 Becton Drive
Franklin Lakes, NJ 07417-1880

Phone : +1.201.847.6800
Web : http://www.bd.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Becton, Dickinson and Company